Barriers and facilitators to conduct high-quality, large-scale safety and comparative effectiveness research: The Biologics and Biosimilars Collective Intelligence Consortium experience

Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):811-813. doi: 10.1002/pds.4885. Epub 2019 Aug 11.
No abstract available

Publication types

  • Consensus Development Conference

MeSH terms

  • Biosimilar Pharmaceuticals*
  • Comparative Effectiveness Research*
  • Humans
  • Research Design

Substances

  • Biosimilar Pharmaceuticals